Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
8.39
-0.11 (-1.29%)
Oct 29, 2026, 3:35 PM EDT - Market open
MRVI Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 208.78 | 185.74 | 259.19 | 288.95 | 883 | 799.24 |
Revenue Growth | -5.03% | -28.34% | -10.30% | -67.28% | 10.48% | 181.32% |
Gross Profit Gross Profit Growth | 74.55 | 35.69 | 108.31 | 140.2 | 714.04 | 658.68 |
Operating Income Operating Income Growth | -68.53 | -125.63 | -72.68 | -28.47 | 569.92 | 543.4 |
Net Income Net Income Growth | -77.39 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Earnings Per Share EPS Growth | -0.53 | -0.91 | -1.05 | -0.90 | 1.67 | 1.56 |
EPS Growth | - | - | - | - | 6.97% | -33.73% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
TriLink TriLink Growth | 142.1 | 119.79 | 196.35 | 224.77 | 813.08 | 712.52 |
Cygnus Cygnus Growth | 66.68 | 65.96 | 62.84 | 64.18 | 69.93 | 68.42 |
Total Total Growth | 208.78 | 185.74 | 259.19 | 288.95 | 883 | 799.24 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 70.09 | 216.89 | 323.77 | 574.96 | 632.14 | 551.27 |
Total Debt Total Debt Growth | 218.1 | 364.71 | 376.69 | 610.97 | 585.26 | 575.22 |
Net Cash (Debt) Net Cash Growth | -148.01 | -147.82 | -52.92 | -36.01 | 46.88 | -23.95 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.01 | -1.02 | -0.38 | -0.27 | 0.18 | -0.09 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -25.26 | -57.57 | 7.47 | 126.22 | 535.98 | 368.57 |
Capital Expenditures CapEx Growth | -10.58 | -13.15 | -29.66 | -65.55 | -17.09 | -14.85 |
Free Cash Flow Free Cash Flow Growth | -35.84 | -70.72 | -22.19 | 60.67 | 518.89 | 353.72 |
Free Cash Flow Growth | - | - | - | -88.31% | 46.69% | 179.00% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.71% | 19.21% | 41.79% | 48.52% | 80.87% | 82.41% |
Operating Margin | -32.82% | -67.64% | -28.04% | -9.85% | 64.54% | 67.99% |
Pretax Margin | -65.38% | -126.50% | -100.89% | 213.79% | 62.45% | 66.41% |
Profit Margin | -37.07% | -70.41% | -55.88% | -41.19% | 24.94% | 22.78% |
FCF Margin | -17.17% | -38.07% | -8.56% | 21.00% | 58.76% | 44.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.55 | 30.26 |
Forward PE | - | 126.02 | 126.02 | 207.05 | 23.42 | 42.82 |
P/FCF Ratio | - | - | - | 14.27 | 3.63 | 15.57 |
PS Ratio | 10.32 | 2.54 | 2.98 | 3.00 | 2.13 | 6.89 |